An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT

Research output: Contribution to journalArticle

Abstract

Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen-targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.

Original languageEnglish (US)
Pages (from-to)e441-e443
JournalClinical Nuclear Medicine
Volume42
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Penile Neoplasms
Prostatic Neoplasms
Molecular Imaging
Residual Neoplasm
Urethra
Prostate-Specific Antigen
Pelvis
Serum
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
human glutamate carboxypeptidase II

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

@article{ef8f0f17bab140e8a23f169bceb73ccf,
title = "An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT",
abstract = "Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen-targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.",
author = "Rowe, {Steven P.} and Gorin, {Michael A.} and Chu, {Linda C.} and Pienta, {Kenneth J.} and Pomper, {Martin G.} and Ross, {Ashley E.} and Macura, {Katarzyna J.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/RLU.0000000000001785",
language = "English (US)",
volume = "42",
pages = "e441--e443",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT

AU - Rowe, Steven P.

AU - Gorin, Michael A.

AU - Chu, Linda C.

AU - Pienta, Kenneth J.

AU - Pomper, Martin G.

AU - Ross, Ashley E.

AU - Macura, Katarzyna J.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen-targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.

AB - Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen-targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.

UR - http://www.scopus.com/inward/record.url?scp=85043243031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043243031&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001785

DO - 10.1097/RLU.0000000000001785

M3 - Article

C2 - 28806262

AN - SCOPUS:85043243031

VL - 42

SP - e441-e443

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 10

ER -